1. Promotes Hepatocellular Carcinoma via Axis Under Insufficient Radiofrequency Ablation Condition.
- Author
-
Li, Zilin, Jiang, Manhong, Zhang, Ting, and Liu, Suhua
- Subjects
- *
RNA metabolism , *LIVER tumors , *GROWTH factors , *CANCER invasiveness , *RNA , *CELL physiology , *TREATMENT effectiveness , *CELL motility , *CELL lines , *HEPATOCELLULAR carcinoma , *CARRIER proteins - Abstract
Background: Hepatocellular carcinoma (HCC) is a common malignancy worldwide. Radiofrequency ablation (RFA) is applied for treating HCC; however, insufficient RFA promotes HCC development and accelerates HCC recurrence. Therefore, the molecular functions underlying this process have gradually attracted attention. Objective: We sought to examine whether GAS6-AS2 (also known as GAS6-DT: growth arrest specific 6 divergent transcript) played a role in the development of HCC after insufficient RFA. Materials and Methods: The in vitro model was established by heating Huh7 and MHCC97 cells in water bath at 47°C, named as Huh7-H and MHCC97-H. Colony formation, transwell and Western blot assays were conducted for functional analysis. Results:GAS6-AS2 was upregulated in Huh7-H and MHCC97-H cells relative to Huh7 and MHCC97 cells. GAS6-AS2 deficiency hampered cell proliferation, migration, invasion, epithelial-mesenchymal transition, and stemness in Huh7-H and MHCC97-H cells. Moreover, microRNA-3619-5p (miR-3619-5p) combined with GAS6-AS2 and ARL2 (ADP ribosylation factor-like GTPase 2) was the target gene of miR-3619-5p. GAS6-AS2 served as the competing endogenous RNA (ceRNA) of ARL2 via absorbing miR-3619-5p. Conclusion: On the whole, present study uncovered a novel ceRNA mechanism of GAS6-AS2/miR-3619-5p/ARL2 in HCC after insufficient RFA, which might shed a new insight into treatment of HCC after insufficient RFA. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF